Table 3 Case series of BCAC previously published between 1990 and April 2021
Authors (country) | N | Mean age (range) | Gender | Mean of tumor size (cm) | Site | Histopathological subtypes | Recurrence |
|---|---|---|---|---|---|---|---|
Wilson et al. (USA) [11] | 29 | 67 (40–90) | F = 17 M = 12 | 2.9 | Parotid gland = 22 Oral cavity = 3 Pharynx = 2 Submandibular gland = 1 Sublingual gland = 1 | Solid = 15 Trabecular = 8 Membranous = 4 Tubular = 2 | 3/18 (16.7%) |
Muller et al. (USA) [16] | 7 | 56 (46–74) | F = 6 M = 1 | 2.7 | Parotid gland = 6 Submandibular gland = 1 | Solid = 5 Membranous = 1 Solid = Membranous = 1 | 2 (28.6%) |
Terada et al. (Japan) [7] | 9 | 52 (27–62) | F = 6 M = 3 | 2.5 | Parotid gland = 9 | Tubular > Trabecular = 4 Trabecular = 2 Tubular = 1 Trabecular > Tubular = 1 Trabecular = Tubular = 1 | 0 |
Gutierrez et al. (USA) [21] | 14* | 59 (31–83) | F = 6 M = 8 | NI | Parotid gland = 14 | NI | 0 |
Rito et al. (Portugal) [18] | 22 | 62.7 (42–83) | F = 8 M = 14 | 3.7 | Parotid gland = 10 Nasal cavity = 5 Other major = 4 Other minor = 3 | NI | 3/21 (14.3%) |
Ellis et al. (USA) [31] | 29 | 58 (27–92) | F = 12 M = 16** | 2.1 | Parotid gland = 24 Submandibular gland = 3 Unknown = 2 | Solid = 19 Membranous = 6 Trabecular = 3 Tubular = 1 | 7 (24.1%) |
Warrick et al. (Canada) [22] | 4 | 62 (46–72) | F = 1 M = 3 | 3.4*** | Parotid gland = 3 Nasal cavity = 1 | Solid = 2 Tubular = 1**** | 1 (25%) |